Balance Sheet

Assets

+39%

+61%

10Y

Currency: IDR

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	4 891	12 152	6 495	10 508	14 199	11 756	28 976	37 403	17 014	18 679	18 323	27 497	18 679	63 420	34 007	33 560	56 462	37 685	29 491	48 054	47 362	25 668	58 900	53 473
Cash	4 891	12 152	6 495	10 508	14 199	11 756	28 976	37 403	17 014	18 679	18 323	27 497	18 679	63 420	34 007	33 560	56 462	37 685	29 491	48 054	47 362	25 668	58 900	53 473
Total Receivables	29 341	33 569	44 728	58 062	71 059	80 683	106 073	135 200	125 374	127 243	147 617	178 159	209 780	221 050	276 407	312 397	351 339	500 564	506 661	498 761	461 074	568 494	682 833	741 593
Accounts Receivables	28 335	32 268	43 399	55 259	70 035	79 425	105 729	134 381	124 992	126 027	145 518	176 008	206 788	216 865	270 537	303 977	347 986	486 634	499 529	476 368	440 453	545 672	659 684	731 940
Other Receivables	1 006	1 301	1 329	2 803	1 024	1 258	344	819	382	1 216	2 099	2 151	2 992	4 184	5 870	8 420	3 352	13 930	7 133	22 393	20 622	22 822	23 149	9 654
Inventory	33 066	39 626	45 327	48 575	60 532	68 889	82 480	108 917	95 851	97 343	119 951	140 021	191 382	193 058	248 973	279 786	321 291	457 507	469 412	389 348	453 301	538 433	535 874	567 732
Other Current Assets	3 135	2 194	2 669	5 105	4 064	3 456	4 212	6 500	5 855	7 240	12 823	19 291	31 299	27 139	48 541	73 815	112 738	98 168	104 976	92 730	108 567	126 363	170 046	200 995
Total Current Assets	70 433	87 541	99 219	122 250	149 853	164 784	221 740	288 021	244 094	250 505	298 714	364 968	451 139	504 808	607 928	699 559	841 829	1 093 924	1 110 540	1 028 893	1 070 305	1 258 959	1 447 652	1 563 794
PP&E Net	8 246	10 110	8 825	8 182	6 989	6 765	8 807	9 433	8 917	7 667	8 065	7 242	8 292	11 144	10 421	15 435	18 197	19 896	24 822	48 139	42 287	46 695	112 594	111 417
PP&E Gross	8 246	10 110	8 825	8 182	6 989	6 765	8 807	9 433	8 917	7 667	8 065	7 242	0	0	0	0	0	0	0	0	0	0	112 594	111 417
Accumulated Depreciation	9 710	13 984	16 161	17 821	19 047	19 410	20 314	15 484	16 850	15 720	15 478	16 263	0	0	0	0	0	0	0	0	0	0	50 588	58 700
Intangible Assets	0	0	0	0	0	0	0	8 621	12 137	11 715	9 875	8 034	6 194	4 353	2 513	673	67	0	0	0	0	8 737	9 142	7 779
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14 400
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54 000	54 000	54 000	54 000	54 000	54 000	33 300	22 508
Other Long-Term Assets	5 844	10 620	8 357	6 358	4 583	3 966	1 566	2 583	2 866	6 628	6 816	5 365	6 053	9 709	12 356	17 777	23 912	25 071	41 482	33 795	39 794	33 114	36 994	51 959
Total Assets	84 523 N/A	108 272 +28%	116 401 +8%	136 790 +18%	161 425 +18%	175 516 +9%	232 113 +32%	308 658 +33%	268 013 -13%	276 516 +3%	323 469 +17%	385 610 +19%	471 677 +22%	530 015 +12%	633 217 +19%	733 443 +16%	938 005 +28%	1 192 891 +27%	1 230 844 +3%	1 164 826 -5%	1 206 386 +4%	1 401 505 +16%	1 639 682 +17%	1 771 857 +8%
Liabilities
Accounts Payable	38 960	42 923	50 495	64 612	77 251	88 031	120 625	135 781	83 407	70 939	99 440	137 996	159 086	150 347	195 848	247 868	316 277	430 114	424 680	408 524	413 383	468 604	17 899	527 590
Accrued Liabilities	5 709	4 650	2 546	308	1 280	1 155	1 465	4 862	8 464	8 027	10 156	12 708	17 941	20 638	22 038	22 735	33 985	37 839	43 433	37 354	48 634	20 961	25 873	22 604
Short-Term Debt	16 875	11 995	15 629	23 249	26 815	23 980	35 122	60 000	67 500	96 175	107 625	114 806	162 066	216 198	258 470	295 833	344 467	421 002	492 688	382 991	454 721	566 080	665 059	798 202
Current Portion of Long-Term Debt	675	1 809	1 569	89	0	0	987	3 007	3 215	49	55	61	56	302	335	349	8	0	0	396	432	468	358	5 009
Other Current Liabilities	1 998	5 140	1 872	3 117	3 344	727	973	13 946	1 654	1 202	155	1 285	1 154	472	744	1 282	4 835	46 971	5 543	73 994	25 419	56 925	577 810	60 012
Total Current Liabilities	64 218	66 517	72 111	91 375	108 690	113 893	159 172	217 596	164 239	176 393	217 432	266 856	340 303	387 958	477 435	568 067	699 571	935 927	966 344	903 258	942 589	1 113 038	1 287 001	1 413 417
Long-Term Debt	714	4 202	2 837	0	0	0	1 009	7 355	6 830	172	117	56	0	680	360	12	0	0	0	2 030	1 798	1 510	44 918	43 311
Minority Interest	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	19
Other Liabilities	476	903	145	237	529	995	1 696	3 951	7 676	9 177	11 144	14 073	16 503	19 659	21 108	22 089	25 819	24 856	29 063	30 342	25 019	28 046	30 050	32 632
Total Liabilities	65 411 N/A	71 622 +9%	75 093 +5%	91 612 +22%	109 219 +19%	114 888 +5%	161 877 +41%	228 902 +41%	178 746 -22%	185 741 +4%	228 693 +23%	280 985 +23%	356 805 +27%	408 297 +14%	498 903 +22%	590 167 +18%	725 391 +23%	960 783 +32%	995 406 +4%	935 630 -6%	969 406 +4%	1 142 595 +18%	1 361 965 +19%	1 489 341 +9%
Equity
Common Stock	54 600	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	72 800	127 400	127 400	127 400	127 400	127 400	127 400	127 400	127 400
Retained Earnings	35 870	35 699	31 042	27 171	20 143	11 722	2 113	7 406	16 918	18 426	22 427	32 276	42 523	49 369	61 966	70 927	82 905	102 398	105 728	99 487	107 270	129 200	159 951	173 167
Additional Paid In Capital	382	451	451	451	451	451	451	451	451	451	451	451	451	451	451	451	2 310	2 310	2 310	2 310	2 310	2 310	2 310	2 310
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4 203	4 203
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16 146	24 564
Total Equity	19 112 N/A	36 650 +92%	41 308 +13%	45 178 +9%	52 206 +16%	60 627 +16%	70 236 +16%	79 756 +14%	89 268 +12%	90 775 +2%	94 777 +4%	104 625 +10%	114 872 +10%	121 718 +6%	134 315 +10%	143 276 +7%	212 615 +48%	232 108 +9%	235 438 +1%	229 196 -3%	236 979 +3%	258 910 +9%	277 717 +7%	282 515 +2%
Total Liabilities & Equity	84 523 N/A	108 272 +28%	116 401 +8%	136 790 +18%	161 425 +18%	175 516 +9%	232 113 +32%	308 658 +33%	268 013 -13%	276 516 +3%	323 469 +17%	385 610 +19%	471 677 +22%	530 015 +12%	633 217 +19%	733 443 +16%	938 005 +28%	1 192 891 +27%	1 230 844 +3%	1 164 826 -5%	1 206 386 +4%	1 401 505 +16%	1 639 682 +17%	1 771 857 +8%
Shares Outstanding
Common Shares Outstanding	581	742	742	742	742	742	742	742	742	742	742	742	742	742	742	742	1 274	1 274	1 274	1 274	1 274	1 274	1 274	1 274

Income Statement Balance Sheet Cash Flow Statement

Millennium Pharmacon International Tbk PT
IDX:SDPC

Balance Sheet

Balance Sheet Decomposition
Millennium Pharmacon International Tbk PT

Balance Sheet
Millennium Pharmacon International Tbk PT

See Also

Company

Help

Tools

Stocks

Millennium Pharmacon International Tbk PT IDX:SDPC

Balance Sheet

Balance Sheet Decomposition Millennium Pharmacon International Tbk PT

Balance Sheet Millennium Pharmacon International Tbk PT

See Also

Company

Help

Tools

Stocks

Millennium Pharmacon International Tbk PT
IDX:SDPC

Balance Sheet Decomposition
Millennium Pharmacon International Tbk PT

Balance Sheet
Millennium Pharmacon International Tbk PT